RE:MackieMr.Monopoly wrote: Theralese Technologies (TSXV:TLT). Mackie research starts coverage with a "speculative buy" rating and a price target of $0.80 (Canadian) on this company developing a treatment for bladder cancer.
Googled and did not find anything ... only one link ( the Big News Network) however that page is also no longer available .... as it was over written even "cached" displayed no results ....
and People are not buying this news ... Sorry